Intracardiac masses: Single center experience within 12 years: I-MASS Study

The aim of this cross-sectional, retrospective, descriptive study was to review and classify cardiac masses systematically and to determine their frequencies. The medical records of 64,862 consecutive patients were investigated within 12 years. Every patient with a cardiac mass imaged by transthorac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American heart journal plus 2022-01, Vol.13, p.100081-100081, Article 100081
Hauptverfasser: Bugra, Zehra, Emet, Samim, Umman, Berrin, Ozer, Pelin Karaca, Sezer, Murat, Baykiz, Derya, Atilgan, Dursun, Tireli, Emin, Dursun, Memduh, Yılmazbayhan, Dilek, Karaayvaz, Ekrem Bilal, Elitok, Ali, Bilge, Ahmet Kaya, Goren, Taner, Umman, Sabahattin, Kumrular, Merve, Yilmaz, Mustafa, Sonsoz, Mehmet Rasih, Engin, Berat, Ayduk, Elif, Aydogan, Mehmet, Cevik, Erdem, Kavak, Ilyas, Orta, Huseyin, Tasdemir, Mucahit, Tuncozgur, Asli, Topcak, Zeynep, Gorgun, Ozerk Dogus, Oztas, Didem Melis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of this cross-sectional, retrospective, descriptive study was to review and classify cardiac masses systematically and to determine their frequencies. The medical records of 64,862 consecutive patients were investigated within 12 years. Every patient with a cardiac mass imaged by transthoracic echocardiography (TTE) and confirmed with an advanced imaging modality such as transesophageal echocardiography (TEE), computed tomography (CT) and/or cardiac magnetic resonance imaging (CMR) was included. Acute coronary syndromes triggering thrombus formation, vegetations, intracardiac device and catheter related thrombi were excluded. Data demonstrated 127 (0.195%) intracardiac masses consisting of 33 (0.050%) primary benign, 3 (0.004%) primary malignant, 20 (0.030%) secondary tumors, 3 (0.004%) hydatid cysts and 68 (0.104%) thrombi respectively. The majority of primary cardiac tumors were benign (91.67%), predominantly myxomas (78.79%), and the less malignant (8.33%). Secondary cardiac tumors were common than the primary malignant tumors (20:3), with male dominancy (55%), lymphoma and lung cancers were the most frequent. Intracardiac thrombi was the majority of the cardiac masses, thrombi accompanying malignancies were in the first range (n = 17, 25%), followed by autoimmune diseases (n = 13, 19.12%) and ischemic heart disease with low ejection fraction (n = 12, 17.65%). This retrospective analysis identified 127 patients with cardiac masses. The majority of benign tumors were myxoma, the most common tumors that metastasized to the heart were lymphoma and lung cancers, and the thrombi associated with malignancies and autoimmune diseases were the most frequent. •The majority of primary cardiac tumors are benign, predominantly myxomas•Primary malignant cardiac tumors are very rare•Secondary cardiac malignant tumors are much more common than the primary malignant tumors with male dominancy•The most common tumors that metastasize to the heart are lymphoma and lung cancer•Intracardiac thrombi is the majority of cardiac masses, thrombi accompanying malignancies are the most frequent followed by autoimmune diseases predominantly located in the right atrium
ISSN:2666-6022
2666-6022
DOI:10.1016/j.ahjo.2021.100081